The efficacy and safety of pyrotinib in treating HER2‐positive breast cancer patients with brain metastasis: A multicenter study

Cancer Medicine ◽

10.1002/cam4.4481 ◽

2021 ◽

Author(s):

Min Gao ◽

Chao Fu ◽

Shanshan Li ◽

Fang Chen ◽

Yongteng Yang ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastasis ◽

Cancer Patients ◽

Multicenter Study ◽

Efficacy And Safety ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Abstract P6-16-08: Prognostic factor of HER2-positive breast cancer patients developed brain metastasis: A multicenter retrospective analysis

10.1158/1538-7445.sabcs14-p6-16-08 ◽

2015 ◽

Author(s):

Naoki Hayashi ◽

Naoki Niikura ◽

Norikazu Masuda ◽

Seiki Takashima ◽

Rikiya Nakamura ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Brain Metastasis ◽

Retrospective Analysis ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Abstract P6-03-06: Assessing occult brain metastasis with CT scan or MRI in HER2-positive breast cancer patients at initial diagnosis

10.1158/1538-7445.sabcs17-p6-03-06 ◽

2018 ◽

Author(s):

C Delbaldo ◽

T Sarrade ◽

B Brieau ◽

B Billemont ◽

J Denis ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastasis ◽

Ct Scan ◽

Cancer Patients ◽

Initial Diagnosis ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

PerTe: efficacy and safety of pertuzumab in “real life setting” for the neoadjuvant treatment of HER2-positive breast cancer patients

Annals of Oncology ◽

10.1093/annonc/mdx424.039 ◽

2017 ◽

Vol 28 ◽

pp. vi36

Author(s):

D. Cianniello ◽

A. Prudente ◽

R. Caputo ◽

M. Piezzo ◽

M. Riemma ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Neoadjuvant Treatment ◽

Real Life ◽

Efficacy And Safety ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Real Life Setting ◽

Positive Breast Cancer

Download Full-text

155P The addition of pyrotinib in early or locally advanced HER2-positive breast cancer patients with no response to two cycles of neoadjuvant therapy: A prospective, multicenter study

Annals of Oncology ◽

10.1016/j.annonc.2021.08.436 ◽

2021 ◽

Vol 32 ◽

pp. S428

Author(s):

Z.G. Yu ◽

B. Xiong ◽

Z. Yang ◽

L. Kong ◽

F. Wang ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Multicenter Study ◽

Locally Advanced ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Prospective Multicenter Study ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis

Breast Cancer Research and Treatment ◽

10.1007/s10549-014-3237-7 ◽

2014 ◽

Vol 149 (1) ◽

pp. 277-284 ◽

Cited By ~ 16

Author(s):

Naoki Hayashi ◽

Naoki Niikura ◽

Norikazu Masuda ◽

Seiki Takashima ◽

Rikiya Nakamura ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Brain Metastasis ◽

Retrospective Analysis ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis

Breast Cancer ◽

10.1007/s12282-015-0631-x ◽

2015 ◽

Vol 23 (5) ◽

pp. 732-739 ◽

Cited By ~ 9

Author(s):

Qian Zhang ◽

Jian Chen ◽

Xiaoli Yu ◽

Gang Cai ◽

Zhaozhi Yang ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastasis ◽

Cancer Patients ◽

Survival Benefit ◽

Whole Brain Radiotherapy ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Brain Radiotherapy ◽

Positive Breast Cancer

Download Full-text

Abstract 4447: Nanoformulation of lapatinib for HER2-positive breast cancer patients with brain metastasis

10.1158/1538-7445.am2011-4447 ◽

2011 ◽

Author(s):

Joyce S. Lee ◽

Juntao Luo ◽

Sonal Desai ◽

Kit S. Lam ◽

Tianhong Li

Keyword(s):

Breast Cancer ◽

Brain Metastasis ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

PerTe: Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer patients—Efficacy and safety of pertuzumab in “real life" setting.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e12654 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e12654-e12654

Author(s):

Daniela Cianniello ◽

Antonella Prudente ◽

Roberta Caputo ◽

Michela Piezzo ◽

Maria Riemma ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Neoadjuvant Treatment ◽

Real Life ◽

Efficacy And Safety ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Real Life Setting ◽

Positive Breast Cancer

Download Full-text

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy: Sequential analysis

10.26226/morressier.596dfd55d462b80292386fa4 ◽

2017 ◽

Author(s):

You-Jeong Seo

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Sequential Analysis ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Pik3ca Mutations ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Validation of the American Joint Committee on Cancer new prognostic stage groups for HER2-positive breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the prospective ShortHER trial

Annals of Oncology ◽

10.1093/annonc/mdz096.002 ◽

2019 ◽

Vol 30 ◽

pp. iii27-iii28

Author(s):

M.V. Dieci ◽

G. Bisagni ◽

A.A. Brandes ◽

A. Frassoldati ◽

M. Donadio ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

American Joint Committee ◽

Positive Breast Cancer

Download Full-text